Setting up a biotech lab for the first time is one of the most consequential capital allocation decisions an early-stage company makes - and it is one of the areas where first-time founders most reliably make expensive mistakes. Biotech lab equipment purchases can swallow a young company's runway before the first experiment begins, and the instruments most commonly purchased are not always the ones most critical to reaching the next funding milestone.
The most efficient biotech startup budgets do not try to build the "perfect lab" upfront - they focus on what is needed to reach the next milestone, then layer in new equipment or upgrades later.
At Lab Pro, we work with biotech startups, established research labs, and pharmaceutical companies throughout California and the United States, supplying lab equipment, chemicals and reagents, and cleanroom consumables. This article identifies the six most common procurement mistakes we see biotech startups make - and what to do instead.
Key Takeaways
- The single most costly biotech lab equipment mistake is purchasing high-cost instruments before the experimental workflow is fully validated - instruments that become underutilized as the science pivots.
- Consumable spend is consistently underestimated in startup lab budgets, often by 40-60% in the first year, resulting in entirely predictable cash-flow crises.
- Refurbished instruments from qualified vendors provide validated performance, often shorter lead times, and significant cost savings - without the performance compromise many founders fear.
- Service contracts, calibration, and preventive maintenance costs are often omitted from startup lab budgets, resulting in unplanned capital calls when instruments break down.
- A milestone-driven equipment procurement approach - buying only what is needed to reach the next inflection point - preserves cash and strategic flexibility as the science develops.
- Supplier relationships matter as much as price: a trusted supplier who understands your workflow, proactively flags supply risks, and supports your documentation requirements is a competitive advantage.
Why Procurement Decisions Define a Startup's Scientific Runway
In biotech, runway is science time. Every dollar spent on underutilized equipment is a dollar unavailable for talent, reagents, or studies that advance the program. Early-stage biotech companies succeed by hitting milestones, whether generating proof-of-concept data, advancing preclinical programs, or preparing for fundraising.
The challenge is that equipment decisions are often made during lab buildout, before research priorities are fully defined. As a result, startups frequently over-specify equipment, overbuy, or replicate academic lab setups that do not fit a capital-constrained environment.
Effective procurement is about prioritization as much as it is about cost. A needs-based approach helps reduce unnecessary spending, improve flexibility, and support sustainable growth.
Mistake 1: Buying Everything New When Refurbished Is Sufficient
Many founders default to buying new equipment because that is standard in academia and large pharmaceutical companies. For startups, however, refurbished equipment is often the smarter choice.
Refurbished centrifuges, biosafety cabinets, balances, incubators, microscopes, pipettes, and autoclaves can deliver the same performance as new models at a fraction of the cost. In most cases, the difference is age and appearance, not functionality.
New equipment is most valuable when performance depends on the latest software or technology, such as certain mass spectrometers, liquid chromatography systems, and next-generation sequencers. For more established instrument categories, refurbished equipment can provide substantial savings without compromising research quality.
Financing options can further reduce upfront costs and preserve capital for hiring, consumables, and R&D.
What to do instead: Categorize equipment by necessity. Purchase new equipment only when the latest capabilities are scientifically required. For proven, stable technologies, consider refurbished alternatives and redirect the savings to higher-priority investments.
Mistake 2: Over-Specifying Instruments Before the Science Is Defined
Another costly mistake is buying advanced instruments before the underlying experiment has been validated. Investing in capabilities that are never used ties up capital without improving outcomes. For example, a flow cytometer with far more parameters than an assay requires may never deliver a return on its added cost.
This often stems from planning for where the science might be in 18 months rather than where it is today. Overbuilding leads to underutilized equipment and unnecessary spending. A more effective approach is to equip only the space and workflows needed now, then expand as programs and data requirements grow.
Commonly over-specified instruments include:
- Flow cytometers with more parameters than the assay panel requires
- Mass spectrometers with unnecessary resolution or ionization capabilities
- Sequencing platforms with excess throughput
- Automated liquid handlers are designed for greater complexity than current workflows demand
What to do instead: Select equipment based on current experimental needs. As research evolves, add capabilities through upgrades or additional instruments rather than paying for unused capacity upfront.
Mistake 3: Underestimating Consumables Spend
Consumables are among the most overlooked expenses in startup lab budgets and among the most critical to day-to-day operations. While equipment dominates upfront spending, consumables determine whether experiments can continue without interruption.
A delayed shipment can disrupt research timelines, delay milestones, and create funding risks for early-stage companies. Yet many startups underestimate how quickly consumables are used once research is fully underway.
Common budgeting gaps include:
- Reagents: Usage during active research can be several times higher than during setup and validation phases.
- PPE and safety supplies: Gloves, gowns, and face protection require ongoing replenishment and should be treated as recurring expenses.
- Cleaning supplies: Wipes, disinfectants, and contamination-control products are essential but often omitted from early budgets.
- Pipette tips and plasticware: High-throughput experiments can consume disposable supplies much faster than expected.
What to do instead: Track actual consumable consumption from day one. After four to eight weeks of operation, you will have accurate consumption data to build a realistic reorder model. Use a supplier with a Subscribe and Save program or VMI capability to automate replenishment of your highest-volume SKUs before shortages develop.
Mistake 4: Ignoring Service And Calibration Costs
Service contracts and calibration are often excluded from early lab budgets but can become high unexpected costs later. Without a maintenance plan, equipment failures can cause downtime, delay experiments, and disrupt milestone-driven research.
For startups, instrument downtime is especially costly because it can delay data generation and require experiments to be repeated. Preventive maintenance helps reduce these risks and keeps critical systems operating reliably.
Calibration is equally important, particularly for labs working under quality or regulatory requirements. Instruments such as balances, pipettes, pH meters, and spectrophotometers require routine calibration to maintain accuracy and support documentation standards.
What to do instead: Before purchasing any instrument, calculate its total cost of ownership. Include annual service contract fees, calibration requirements, preventive maintenance expenses, and expected consumable costs. This provides a more accurate view of the long-term investment and helps prevent budget surprises.
Mistake 5: Building The Lab For Year Three Instead Of Year One
Many startups make the mistake of building labs for their future scale rather than their current needs. Founders often design facilities around a fully staffed operation with multiple research programs, then spend valuable capital on infrastructure and equipment that may not be needed for years.
A more efficient approach is to invest only in the capabilities required to reach the next milestone. Shared lab resources, core facilities, and CRO partnerships can provide access to specialized equipment without the cost of ownership, particularly in high-cost biotech hubs.
Areas where outsourcing or shared access often makes the most financial sense include:
- Mass spectrometry and proteomics
- Cryo-EM and advanced microscopy
- Next-generation sequencing
- Animal research facilities
- Specialized analytical chemistry, including NMR and X-ray crystallography
What to do instead: Build your equipment plan around near-term milestones. Purchase only the instruments required to generate the next critical dataset, and use shared resources or external partners for infrequent or highly specialized capabilities.
Mistake 6: Choosing Suppliers Based on Price Alone
Choosing suppliers based solely on price can create costs that far outweigh any savings. Lower-priced suppliers may have longer lead times, inconsistent documentation, limited inventory, or poor communication, all of which can disrupt research and delay key milestones.
For startups, a delayed shipment is more than a procurement issue-it can postpone experiments, slow data generation, and impact funding timelines. Reliable supply, consistent product quality, and responsive support often provide greater value than the lowest unit cost.
Strong supplier relationships also improve visibility into potential delays, inventory constraints, and product changes, allowing labs to plan proactively rather than react to disruptions.
What to do instead: Evaluate suppliers on total value, including lead-time reliability, documentation support, lot traceability, inventory programs, and responsiveness. A dependable supplier can help reduce operational risk and keep research programs on schedule.
A Smarter Procurement Framework for Biotech Startups
The six mistakes above share a common root cause: procurement decisions made without a framework. The following four questions, applied to every significant purchase, prevent most of these errors.
| Question | What It Prevents |
|---|---|
| What milestone does this instrument enable? | Over-specification and premature purchase |
| What is the 5-year total cost of ownership? | Ignoring service, calibration, and consumables costs |
| Is a new one required, or will a refurbished one perform equivalently? | Unnecessary capital spend on commodity instruments |
| What is our plan if this supplier has a 4-week delay? | Single-source supply chain fragility |
Applying these principles to every purchase decision helps startups avoid unnecessary spending and preserve capital for research. The most common procurement mistakes occur when labs are built for a future vision rather than the next milestone. By purchasing only what is needed today, accurately forecasting operating costs, and prioritizing value over price alone, startups can extend their runways and scale more efficiently.
At Lab Pro, we help biotech startups and research organizations align equipment and consumable purchases with their current needs. Our portfolio includes laboratory equipment, chemicals, reagents, accessories, and cleanroom consumables, backed by the documentation required to support quality and compliance programs.
For teams looking to simplify inventory management, our Vendor Managed Inventory (VMI) program helps maintain consistent supply levels by proactively replenishing high-use items, reducing the risk of shortages that can disrupt research timelines.
Enhance your lab's efficiency and accuracy.
FAQs
How much should a biotech startup budget for consumables when purchasing biotech lab equipment?
Many startups focus on the cost of lab equipment and underestimate ongoing consumable expenses. A common starting point is to allocate 20–30% of the equipment budget to first-year consumables, then adjust based on actual usage. Tracking consumption from the first few months of operation provides the most accurate basis for future budgeting and inventory planning.
Can refurbished biotech lab equipment be used in regulated environments?
Yes. Refurbished lab equipment can be used in GLP, GMP-adjacent, and other regulated environments if it is properly qualified and documented. Installation, operational, and performance qualifications verify that equipment meets required standards. In many cases, refurbished systems deliver the same functionality as new instruments at a lower cost.
What biotech lab equipment should an early-stage startup buy first?
The first biotech lab equipment purchases should support the next critical research milestone. For many biology-focused startups, that means essentials such as biosafety cabinets, incubators, and centrifuges. Rather than building a fully equipped lab immediately, prioritize the instruments required to generate the data needed for the next funding, development, or validation stage.
Should biotech startups lease or buy lab equipment?
The decision depends on utilization, budget, and technology lifecycle. Leasing biotech lab equipment can be attractive when preserving capital is a priority or when equipment may become obsolete quickly. For instruments that will be used daily for years, purchasing refurbished equipment, particularly, often provides better long-term value.
How can startups avoid overspending on biotech lab equipment?
The best approach is to select biotech lab equipment based on current experimental requirements rather than future possibilities. Define the throughput, sensitivity, and workflow needs of your existing research program, then choose equipment that meets those requirements without excessive unused capacity. Additional capabilities can often be added later as programs grow.
Comments
Loading comments...